Xiangfei Zhao

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model.

Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model.

Journal: ImmunoTargets and therapy

Published: January 20, 2026

Screening and identification of key genes related to the immune microenvironment of rectal cancer influenced by radiotherapy based on bioinformatics methods.

Screening and identification of key genes related to the immune microenvironment of rectal cancer influenced by radiotherapy based on bioinformatics methods.

Journal: Discover oncology

Published: January 08, 2026

Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer.

Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer.

Journal: Journal of translational internal medicine

Published: July 31, 2024

Transarterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC) combined with PD-1 inhibitors plus lenvatinib as a preoperative conversion therapy for nonmetastatic advanced hepatocellular carcinoma: a single center experience.

Transarterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC) combined with PD-1 inhibitors plus lenvatinib as a preoperative conversion therapy for nonmetastatic advanced hepatocellular carcinoma: a single center experience.

Journal: Translational cancer research

Published: January 12, 2024

Hepatic arterial infusion chemotherapy combined with bevacizumab plus a PD-1 inhibitor for gallbladder cancer with hepatic oligometastasis: a real-world study.

Hepatic arterial infusion chemotherapy combined with bevacizumab plus a PD-1 inhibitor for gallbladder cancer with hepatic oligometastasis: a real-world study.

Journal: Journal of gastrointestinal oncology

Published: September 29, 2023

Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment.

Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment.

Journal: Medical oncology (Northwood, London, England)

Published: June 06, 2023

Induction of ligustrazine apoptosis of A549 cells through activation of death receptor pathway.

Induction of ligustrazine apoptosis of A549 cells through activation of death receptor pathway.

Journal: Translational cancer research

Published: January 17, 2022

Abscopal effect of radiation on lymph node metastasis in esophageal carcinoma: A case report and literature review.

Abscopal effect of radiation on lymph node metastasis in esophageal carcinoma: A case report and literature review.

Journal: Oncology letters

Published: February 11, 2018

Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.

Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.

Journal: Oncotarget

Published: September 08, 2016

Growth inhibitory effect of adenovirus-mediated tissue-targeted expression of ribosomal protein L23 on human colorectal carcinoma cells.

Growth inhibitory effect of adenovirus-mediated tissue-targeted expression of ribosomal protein L23 on human colorectal carcinoma cells.

Journal: Oncology reports

Published: March 15, 2015

Comparative proteomic analysis of anti-cancer mechanism by periplocin treatment in lung cancer cells.

Comparative proteomic analysis of anti-cancer mechanism by periplocin treatment in lung cancer cells.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: February 04, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026